These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 24768064)
1. [Dormancy of Candida albicans ATCC10231 in the presence of amphotericin B. Investigation using the scanning electron microscope (SEM)]. Benmansour W; Boucherit-Otmani Z; Boucherit K J Mycol Med; 2014 Sep; 24(3):e93-100. PubMed ID: 24768064 [TBL] [Abstract][Full Text] [Related]
2. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687 [TBL] [Abstract][Full Text] [Related]
3. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B. Yang C; Gong W; Lu J; Zhu X; Qi Q J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268 [TBL] [Abstract][Full Text] [Related]
4. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. Khan MS; Ahmad I J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355 [TBL] [Abstract][Full Text] [Related]
5. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans. Kumar R; Shukla PK Fungal Biol; 2010; 114(2-3):189-97. PubMed ID: 20943129 [TBL] [Abstract][Full Text] [Related]
6. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398 [TBL] [Abstract][Full Text] [Related]
7. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo. Cacciapuoti A; Gurnani M; Halpern J; Norris C; Patel R; Loebenberg D Antimicrob Agents Chemother; 2005 Feb; 49(2):638-42. PubMed ID: 15673745 [TBL] [Abstract][Full Text] [Related]
8. Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agents. Kim KS; Kim YS; Han I; Kim MH; Jung MH; Park HK PLoS One; 2011; 6(12):e28176. PubMed ID: 22174777 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre. Ding CH; Wahab AA; Muttaqillah NA; Tzar MN J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581 [TBL] [Abstract][Full Text] [Related]
10. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100 [TBL] [Abstract][Full Text] [Related]
11. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972 [TBL] [Abstract][Full Text] [Related]
12. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
13. A novel anti Candida albicans drug screening system based on high-throughput microfluidic chips. Qiang L; Guo J; Han Y; Jiang J; Su X; Liu H; Qi Q; Han L Sci Rep; 2019 May; 9(1):8087. PubMed ID: 31147583 [TBL] [Abstract][Full Text] [Related]
14. Dormancy of Candida albicans cells in the presence of the polyene antibiotic amphotericin B: simple demonstration by flow cytometry. Boucherit Z; Seksek O; Bolard J Med Mycol; 2007 Sep; 45(6):525-33. PubMed ID: 17710622 [TBL] [Abstract][Full Text] [Related]
16. In vitro method to study antifungal perfusion in Candida biofilms. Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686 [TBL] [Abstract][Full Text] [Related]
17. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency. Tabbene O; Azaiez S; Di Grazia A; Karkouch I; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML J Appl Microbiol; 2016 Feb; 120(2):289-300. PubMed ID: 26669801 [TBL] [Abstract][Full Text] [Related]
18. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo. Chalkley LJ; Trinci AP; Pope AM Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
20. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms. Mukherjee PK; Long L; Kim HG; Ghannoum MA Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]